Phase II trial of NP-001 in patients with amyotrophic lateral sclerosis
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
At a glance
- Drugs NP-001 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacodynamics
- 04 Apr 2016 According to a Neuraltus Pharmaceuticals media release, this trial is expected to initiated during the summer of 2016.
- 04 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016, according to a Neuraltus Pharmaceuticals media release.
- 02 Jul 2015 New trial record